Jefferies Financial Group Comments on Edap Tms S.A.’s FY2022 Earnings (NASDAQ:EDAP)

Edap Tms S.A. (NASDAQ:EDAPGet Rating) – Stock analysts at Jefferies Financial Group upped their FY2022 earnings per share estimates for shares of Edap Tms in a report issued on Thursday, November 17th. Jefferies Financial Group analyst M. Sarcone now expects that the medical equipment provider will earn $0.06 per share for the year, up from their previous forecast of $0.03. Jefferies Financial Group currently has a “Buy” rating and a $11.00 price target on the stock. The consensus estimate for Edap Tms’ current full-year earnings is $0.04 per share. Jefferies Financial Group also issued estimates for Edap Tms’ Q4 2022 earnings at ($0.01) EPS, FY2024 earnings at $0.02 EPS and FY2025 earnings at $0.11 EPS.

Edap Tms (NASDAQ:EDAPGet Rating) last posted its quarterly earnings results on Wednesday, August 24th. The medical equipment provider reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.09. Edap Tms had a net margin of 6.76% and a return on equity of 6.42%. The company had revenue of $14.97 million for the quarter, compared to analyst estimates of $14.17 million.

A number of other research analysts have also weighed in on EDAP. TheStreet raised shares of Edap Tms from a “c” rating to a “b-” rating in a research note on Thursday. StockNews.com began coverage on shares of Edap Tms in a research note on Wednesday, October 12th. They issued a “hold” rating on the stock. Piper Sandler raised their price target on shares of Edap Tms from $11.00 to $12.00 in a research note on Thursday. Lake Street Capital increased their price objective on shares of Edap Tms from $12.00 to $14.00 in a report on Friday. Finally, HC Wainwright increased their price objective on shares of Edap Tms from $11.00 to $12.00 and gave the company a “buy” rating in a report on Friday.

Edap Tms Trading Down 3.8 %

EDAP stock opened at $9.95 on Monday. The company’s 50-day simple moving average is $8.86 and its 200-day simple moving average is $7.73. The company has a quick ratio of 3.18, a current ratio of 4.37 and a debt-to-equity ratio of 0.08. Edap Tms has a 52-week low of $5.13 and a 52-week high of $10.60. The firm has a market cap of $359.64 million, a P/E ratio of 90.46 and a beta of 1.22.

Institutional Trading of Edap Tms

Institutional investors have recently added to or reduced their stakes in the stock. Maven Securities LTD purchased a new stake in shares of Edap Tms during the 3rd quarter worth $671,000. BNP Paribas Arbitrage SNC acquired a new stake in Edap Tms during the 3rd quarter worth $54,000. Caas Capital Management LP acquired a new stake in Edap Tms during the 3rd quarter worth $392,000. Commonwealth Equity Services LLC raised its stake in Edap Tms by 11.2% during the 3rd quarter. Commonwealth Equity Services LLC now owns 58,085 shares of the medical equipment provider’s stock worth $479,000 after acquiring an additional 5,860 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in Edap Tms by 136.4% during the 3rd quarter. Royal Bank of Canada now owns 13,000 shares of the medical equipment provider’s stock worth $107,000 after acquiring an additional 7,500 shares in the last quarter. Institutional investors and hedge funds own 28.53% of the company’s stock.

About Edap Tms

(Get Rating)

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).

Recommended Stories

Earnings History and Estimates for Edap Tms (NASDAQ:EDAP)

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.